Skip to main content

Year: 2024

La Rosa Holdings to Unveil Proprietary Technology Advancements at Growth Summit 2024

Celebration, FL, Nov. 07, 2024 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a holding company for six agent-centric, technology-integrated, cloud-based, multi-service real estate segments, today announced the commencement of its Growth Summit 2024 in Orlando, Florida, starting at 10 a.m. EST. During the event, the Company will unveil advancements in its proprietary real estate technology. The summit is at capacity, with all 500 tickets claimed. Attendees will gain insights into the latest tools and innovations designed to drive agent success, enhance productivity, and help to position La Rosa as a leader in real estate technology. My Agent Account, La Rosa’s proprietary platform, was designed to empower agents with a comprehensive suite of tools and resources. Serving as a centralized...

Continue reading

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

DUBLIN, Nov. 07, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that on November 6, 2024, it received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum market value of publicly held shares (“MVPHS”) requirement under Nasdaq Listing Rule 5450(b)(2)(C) (the “MVPHS Requirement”). “One of my top priorities when taking on the role of CEO last December was to address the pre-existing Nasdaq listing requirement deficiencies. This has now been achieved and we are pleased to have regained compliance with Nasdaq’s listing requirements. We are grateful for the continued support of our shareholders,...

Continue reading

GlobalTech Corporation and Techtics AI Align to Drive Innovation in Emerging Technologies

RENO, Nev., Nov. 07, 2024 (GLOBE NEWSWIRE) — GlobalTech Corporation (GTC, OTC:GTLK), a leading U.S.-based technology investment holding company, and Techtics AI, a cutting-edge AI solutions provider, have entered into a strategic alliance to deliver cutting-edge technology solutions. GlobalTech would market the AI products to USA, Middle East and European markets through its network and Techtics would be responsible for enhancement of existing products as well as development of new and scalable AI products. This collaboration aims to leverage the transformative potential of Artificial Intelligence (AI), Big Data, Generative AI (GenAI), and other emerging technologies to meet the evolving demands of today’s digital and connected world. It is anticipated that this collaboration, built on a shared vision of fostering innovation and...

Continue reading

Enlight Announces a Power Purchase Agreement for the Snowflake A Project in Arizona

TEL AVIV, Israel, Nov. 07, 2024 (GLOBE NEWSWIRE) — Enlight Renewable Energy (“Enlight”, “the Company”, NASDAQ: ENLT, TASE: ENLT.TA), a leading renewable energy platform, announces that its U.S. subsidiary Clenera has signed a new power purchase agreement (“PPA”) with Arizona Public Service (“APS”) for its Snowflake A Project (“Snowflake A” or “the Project”). The busbar fixed price PPA encompasses the Project’s 600 MW of solar generation capacity and 1900 MWh of energy storage availability, and is for a duration of 20 years. Snowflake A is located near Holbrook, Arizona, in the northeastern part of the state, an area with very high solar irradiation. The Project is in the final stages of pre-construction permitting, and assuming all necessary permits are obtained, is expected to reach ready to build (RTB) status in the third...

Continue reading

The Metals Company Announces Third Quarter 2024 Corporate Update Conference Call for Thursday, November 14, 2024 

NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) — The Metals Company (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, today announced that it will host a conference call on Thursday, November 14, 2024, to provide an update on third quarter financial results and recent corporate developments.  Third Quarter 2024 Conference Call Details Date:  Thursday, November 14, 2024   Time:  4:30 p.m. ET   Audio-only Dial-in:  Register Here   Virtual webcast with slides:  Register Here   The virtual webcast will be available for replay in the ‘Investors’ tab of the Company’s website under ‘Investors’ > ‘Media’ > ‘Events and Presentations’, approximately two hours after the event. About The Metals Company The Metals Company is an explorer of lower-impact...

Continue reading

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

THB335 Phase 1 SAD/MAD clinical trial on track to deliver clinical results in 1Q’25 Strong financial position with cash and cash equivalents totaling $296.1 million as of September 30, 2024 SAN FRANCISCO, Nov. 07, 2024 (GLOBE NEWSWIRE) — Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory and gastrointestinal inflammatory diseases, today announced financial results for the third quarter September 30, 2024. “As the Phase 1 clinical trial of our development candidate THB335 continues toward an anticipated data readout in the first quarter of 2025, we are also making excellent progress in preparing to move efficiently into a Phase 2 clinical trial in chronic spontaneous urticaria,” said Natalie Holles, Chief Executive Officer at...

Continue reading

Cassava Sciences Reports Q3 2024 Financial and Operating Results

Top-line Data for RETHINK-ALZ 52-week Phase 3 trial Expected Before the End of 2024$149.0 Million in Cash and Cash Equivalents at September 30, 2024. Expected To Support Operations Into 2026Conference Webcast Scheduled for Today at 8:30AM ETAUSTIN, Texas, Nov. 07, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on developing a novel treatment for Alzheimer’s disease, today reported financial results for the third quarter ended September 30, 2024. “We look forward to the release of top-line results from RETHINK-ALZ, our first Phase 3 trial for simulfilam, by the end of 2024,” said Rick Barry, President and Chief Executive Officer. “This will represent the culmination of three-plus years of concerted effort by our clinical team, principal investigators, patients...

Continue reading

Vericel Reports Third Quarter 2024 Financial Results

Total Revenue Growth of 27% to $57.9 Million Gross Margin of 72% and Adjusted EBITDA Growth of 84% Full-Year Profitability Guidance Raised FDA Approval and Commercial Launch of MACI Arthro in Third Quarter Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the third quarter ended September 30, 2024. Third Quarter 2024 Financial HighlightsTotal net revenue of $57.9 million MACI® net revenue growth of 19% to $44.7 million Burn Care net revenue growth of 66% to $13.2 million, consisting of $12.2 million of Epicel® revenue and $1.1 million of NexoBrid® revenue Gross margin of 72%, an increase of 480 basis points...

Continue reading

Sunrise Realty Trust, Inc. Announces Financial Results for Third Quarter 2024

Third quarter 2024 GAAP net income of $1.7 million or $0.26 per basic weighted average common share and Distributable Earnings(1) of $1.9 million or $0.27 per basic weighted average common share WEST PALM BEACH, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (NASDAQ:SUNS) (“SUNS” or the “Company”) today announced its results for the quarter ended September 30, 2024. SUNS reported generally accepted accounting principles (“GAAP”) net income of $1.7 million or $0.26 per basic weighted average common share and Distributable Earnings of $1.9 million or $0.27 per basic weighted average common share for the third quarter of 2024. “Our strong performance this quarter highlights the continued momentum we’ve maintained since our listing as an independent, public company,” said Brian Sedrish, the Company’s Chief...

Continue reading

First Watch Restaurant Group, Inc. Reports Q3 2024 Financial Results

Total revenues increased 14.8%Net income of $2.1 million and Adjusted EBITDA growth of 18% to $25.6 million9 new system-wide restaurants opened in 8 states BRADENTON, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today reported financial results for the thirteen weeks ended September 29, 2024 (“Q3 2024”). “We are pleased with our performance in Q3 as it reflects our teams’ superb restaurant-level operations, especially considering an uneven consumer backdrop. Traffic picked up through the quarter, our employee turnover once again improved and remains favorable relative to the industry as a whole and Adjusted EBITDA grew 18%,” said Chris Tomasso, First Watch CEO and President. “We are...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.